Authors

• Peng Yuan (ORCID: https://orcid.org/0000-0002-5968-0368)
• Tingrong Huang
• Jia Ke
• Zhimin Zhao (ORCID: https://orcid.org/0009-0000-8956-8804)
• Qiwu Qiu
• Jiawen Feng
• Feng Xing (ORCID: https://orcid.org/0000-0001-5209-9143)
• Fei Jing
• Jihan Huang (ORCID: https://orcid.org/0000-0002-2176-737X)
• Wei Wang (ORCID: https://orcid.org/0000-0001-5667-2306)
• Wei Zhang (ORCID: https://orcid.org/0000-0001-8693-6747)
• Songhua Zhan
• Hui Wu (ORCID: https://orcid.org/0000-0003-3669-0915)
• Bo Jiang (ORCID: https://orcid.org/0009-0000-9929-9943)
• Chenghai Liu (ORCID: https://orcid.org/0000-0002-2033-0934)
• Wen Su

Institutions

• Ministry of Education of the People's Republic of China (CN)
• Hubei University of Chinese Medicine (CN)
• Shanghai University of Traditional Chinese Medicine (CN)
• Integrated Chinese Medicine (China) (HK)
• Wuhan No.1 Hospital (CN)
• Wuhan Third Hospital (CN)
• Shuguang Hospital (CN)
• Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
• Huangshi Central Hospital (CN)

Publication Details

Journal

Frontiers in Pharmacology

Published

2025-03-11

DOI

https://doi.org/10.3389/fphar.2025.1508276

Citations

2

Primary Topic

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Type

article

Field-Weighted Citation Impact

3.04

Funders

• National Key Research and Development Program of China